Ad hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
View Featured news and Pulse updates.
Header
Newsroom
Showing 102 results
April 2020
-
Featured News
World Chagas Disease Day 2020
Novartis is committed to reimagining the fight against Chagas Disease and advocating for an integrated, end-to-end care approach. -
Featured News
Novartis COVID-19 Response Fund provides support to healthcare workers and communities
Novartis COVID-19 Response Fund is providing urgently-needed support for healthcare workers and communities in over 50 projects around the world.
March 2020
-
Featured News
Novartis coronavirus update (remote working, business travel restrictions)
-
Featured News
Novartis provides update on use and safety of Beovu® in patients with wet AMD
-
Featured News
International Women’s Day 2020
To celebrate International Women’s Day we explore how an inclusive environment that values unique and curious minds helps everyone be inspired to innovate every day.
January 2020
-
Featured News
Novartis at the World Economic Forum Annual Meeting Davos 2020
From January 21-24 2020, Novartis attended the World Economic Forum Annual Meeting in Davos, Switzerland.
-
Featured News
Novartis at J.P Morgan 2020
From January 13-16 2020, Novartis attended the J.P Morgan Healthcare Conference in San Francisco.
December 2019
-
Featured News
Uncovering profound and under-reported effects on people living with sickle cell disease
Results of the Sickle Cell World Assessment Survey (SWAY) highlight the impact this debilitating disease has on patients and their families. -
Featured News
Novartis R&D Day
Novartis shares progress in advancing its industry-leading R&D pipeline. We are uniquely positioned to deliver transformational treatments through our scale, focus on innovative medicines, diverse range of therapeutic areas and exposure to cutting-edge platforms.
-
Featured News
Amazon Web Services (AWS) announces strategic collaboration with Novartis to accelerate digital transformation of its business operations
-
Featured News
Behind the research driving our data at medical conferences
Novartis data at 2019 ASH and SABCS underscore our evolving R&D approach in innovative platforms to reimagine medicine and help improve patient outcomes.